Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Doctor Glasses (300622) net buy by main funds of 4.5277 million yuan on April 8
According to Securities Star news, as of the close on April 8, 2026, Dr. Eye Glasses (300622) closed at 24.16 yuan, up 5.64%, with a turnover rate of 4.59%, a trading volume of 71.5k lots, and a transaction value of 171 million yuan.
Regarding the capital flow data on April 8, the main funds had a net inflow of 4.5277 million yuan, accounting for 2.66% of the total transaction amount; retail funds had a net outflow of 71.5k yuan, accounting for 1.41%; and retail investors’ funds had a net outflow of 2.1267 million yuan, accounting for 1.25%.
Dr. Eye Glasses’ 2025 third-quarter report shows that in the first three quarters, the company’s main business revenue was 1.08 billion yuan, an increase of 18.05% year-on-year; net profit attributable to the parent was 87.8313 million yuan, up 5.21% year-on-year; net profit after deducting non-recurring gains and losses was 78.9989 million yuan, up 7.82% year-on-year; among them, in the third quarter of 2025, the company’s single-quarter main business revenue was 394 million yuan, an increase of 25.39% year-on-year; net profit attributable to the parent was 31.7978 million yuan, up 2.24% year-on-year; net profit after deducting non-recurring gains and losses was 29.3537 million yuan, up 7.11% year-on-year; debt ratio was 35.3%, investment income was 6.2162 million yuan, financial expenses were 5.7057 million yuan, and gross profit margin was 53.76%. Dr. Eye Glasses (300622) main business: specializes in retail chain eyewear operations, committed to providing consumers with fashionable, personalized eyewear products and professional visual health solutions.
In the past 90 days, this stock has received ratings from one institution, which gave a buy rating.
Explanation of capital flow terminology: It refers to inferring capital flow direction through price changes. When the stock price is rising, the transaction volume generated by active buy orders is the force driving the stock price up, which is defined as capital inflow. When the stock price is falling, the transaction volume generated by active sell orders is the force driving the stock price down, which is defined as capital outflow. The difference between the two on the same day is the net force remaining after the two forces oppose each other, driving the stock price higher. The main fund flow, retail fund flow, and small retail investor fund flow are calculated based on transaction amounts of individual trades.
Note: Main funds refer to large orders, retail funds refer to medium and small orders, and retail investors refer to small orders.
The above content is compiled from public information by Securities Star, generated by AI algorithm (Wangxin Suanbei 310104345710301240019), and does not constitute investment advice.